NCT06907693View on ClinicalTrials.gov

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

Active, not recruitingOBSERVATIONAL

Enrollment

7

Participants

Timeline

Start Date

March 14, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 15, 2026

Conditions

Pulmonary Arterial Hypertension

Interventions

DIAGNOSTIC_TEST

CT Pulmonary Angiography Scan

Computed tomography (CT) pulmonary angiography scan of the chest with IV contrast

Trial Locations (1)

29605

Prisma Health, Greenville

Sponsors

Collaborators (1)

Cereno Scientific AB

All Listed Sponsors

collaborator

Cereno Scientific AB

INDUSTRY

lead

Prisma Health-Upstate

OTHER

NCT06907693 - The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI | Biotech Hunter | Biotech Hunter